Testing effectiveness (Phase 2)Ended earlyNCT01239355
What this trial is testing
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 15